Tag: donald trump
Jerome Powell

Fed Chair Bluntly Warns Trump Tariffs Will Risk Inflation And Recession

On Wednesday, Federal Reserve Chair Jerome Powell defended the bank's decision to stabilize interest rates. He said that, while the economy seems solid, President Donald Trump's tariffs increase the risk of inflation and unemployment, warranting a pause in monetary policy to see how things go.

“If the large increases in tariffs that have been announced are sustained, they're likely to generate a rise in inflation, a slowdown in economic growth, and an increase in unemployment,” Powell said during a press conference.

A simultaneous increase in unemployment and inflation is known as "stagflation," which is not only rare but is also exceedingly difficult for the Federal Reserve and policymakers to solve, since the tactics that they would usually use to fix one would exacerbate the other.

For example, lowering interest rates leads to economic and job growth, but it often spikes inflation. Conversely, raising rates leads to slower growth that helps ease inflation, but it doesn’t help jumpstart the job market.

“The Fed didn't use the word ‘stagflation,’ but that's what it's warning about. Never a good moment when your central bank says that it's worried about *both* higher unemployment and higher inflation. That's a problem that monetary policy alone can't solve,” Justin Wolfers, an economics professor at the University of Michigan, wrote on X.

The Federal Reserve's decision to stabilize interest rates is likely to piss off Trump, who has demanded that Powell cut rates.

"The [European Central Bank] is expected to cut interest rates for the 7th time, and yet, 'Too Late' Jerome Powell of the Fed, who is always TOO LATE AND WRONG, yesterday issued a report which was another, and typical, complete 'mess!' Oil prices are down, groceries (even eggs!) are down, and the USA is getting RICH ON TARIFFS. Too Late should have lowered Interest Rates, like the ECB, long ago, but he should certainly lower them now. Powell’s termination cannot come fast enough!" Trump wrote on Truth Social on April 17.

He has even threatened to fire Powell for not lowering interest rates, only backing off when the stock market tanked as investors feared that Trump would end the Federal Reserve’s independence.

Meanwhile, Democrats are already seizing on Powell’s warning that tariffs could lead to stagflation.

"Donald Trump's tariffs mean you could suffer higher prices and lose your job AT THE SAME TIME. Forget dolls, families will be forced to make impossible choices between necessities like food, housing, and health care," Sen. Elizabeth Warren of Massachusetts wrote on X.

But even as the economic warning lights are flashing red, Trump says that he has no plans to lift his tariffs on Canada, a major U.S. trading partner, and that he is fine with a trade embargo on China.

"By not trading, we're losing nothing. So we're saving a trillion dollars. That's a lot,” Trump falsely claimed during a meeting with Canada’s newly elected Prime Minister Mark Carney on Tuesday.

Instead, he’s telling Americans that their children will just have to deal with having fewer toys. But if Trump keeps up his idiotic tariffs, the pain will be felt much further than the toy store.

Reprinted with permission from Daily Kos.

Why Trump's Latest FDA Appointee May Imperil Agency's Vital Work

Why Trump's Latest FDA Appointee May Imperil Agency's Vital Work

By appointing Dr. Vinay Prasad to run the Center for Biologics Evaluation and Research, the Trump regime has installed another prominent opponent of Covid-era public health policies to a key position at the Food and Drug Administration.

CBER is responsible for ensuring the safety and efficacy of vaccines, biologic drugs, gene therapies and the blood supply. When FDA Commissioner Martin Makary announced Prasad’s appointment yesterday, he noted the 42-year-old oncologist-epidemiologist has published hundreds of articles in the medical literature. I read their titles this morning. Only a few shed light on how he views the arenas he will soon oversee.

On the other hand, his recent writings on X (formerly Twitter), the substack Sensible Medicine, and his own substack Observations and Thoughts have plenty to say about school closures (“the great domestic policy failure of the last 25 years”); kids wearing masks outdoors (“whoever made the policy is an idiot”); and the annual Covid booster shot (“a public health disaster the likes of which we’ve never seen before”).

On the day after Trump’s election last November, he gave failing grades to the FDA and National Institutes of Health. He called for the elimination of 10,000 jobs at the Centers for Disease Control and Prevention, which he rated as an “abject failure.”

The rhetoric sounds more Trump/Muskian than even-handed or scientific. It is typical of his recent writings, which have taken on an increasingly strident tone since the pandemic. He has repeatedly attacked officials like Anthony Fauci and those at the CDC for ignoring alternative strategies and censoring proponents of herd immunity like Jay Bhattacharya, who now runs NIH.

One of Prasad’s recent posts called for large-scale, randomized clinical trials for the annual booster shots for COVID vaccines. That was in line with Makary’s order late last month that Novavax conduct a new clinical trial to test the annual update of its traditional Covid vaccine, which is the only alternative to the mRNA vaccines sold by Pfizer and Moderna. This new requirement may also be applied to the annual flu vaccines, which will cost the vaccine makers money (who cares?), but more importantly, will take much more time (something we should all care about).

“The FDA is a failure,” Prasad wrote last fall. “It rubber stamps too many useless products. It needs to either remove itself from the picture, or demand randomized trials measuring appropriate endpoints.”

Right turn

This rightward turn in Prasad’s public posture is a relatively recent phenomenon. He began his academic career by studying conflicts of interest in medicine (my own field when working at the Center for Science in the Public Interest). In 2017, he published a study in JAMA Internal Medicine that challenged the ridiculously high sum big drug companies claimed it cost to develop a new drug. (Full disclosure: I was invited to write the accompanying editorial, which was headlined “A Much-Needed Corrective on Drug Development Costs”).

To this day, the insidious role money plays in medicine remains central to how he views the relationship between the drug industry and government. “This is the core rot in American regulation. The revolving door politics. I find this behavior abhorrent, and it should be criminal,” he has written.

He has called for ending all conflicts of interest on FDA advisory committees and wants to set up a “new Phase IV safety detection system” for monitoring adverse vaccine events. “I think vaccine makers should face litigation, as drug makers do,” he has written. He’s also skeptical of using surrogate endpoints and accelerated approvals, which led the FDA to “rubber stamp dozens of drugs with no evidence they help Americans.”

So here we are again. A top Trump regime appointee is championing many positions held by left wing and progressive critics of weak government oversight. Indeed, Prasad has written he once considered himself a progressive Democrat. No wonder biotech stocks temporarily tanked on news of Prasad’s appointment to run CBER.

However, as I’ve said many times in writing about these appointments, let’s watch what they do, not what they say, past or present. Will the Makary/Prasad team slow or even stop vaccine approvals to please their boss, Robert F. Kennedy Jr., the secretary of Health and Human Services? Will Trump order the new team to back off from policies and decisions that tank the stock market (vaccines on their own could never do that; they’re too small a revenue item)?

If I were a gambling man, I’d bet the answer will be ‘yes’ to both those questions.

Reprinted with permission from Gooz News.

House Republicans Urge New Social Security Chief To Act With 'Caution'

House Republicans Urge New Social Security Chief To Act With 'Caution'

After financial services executive Frank Bisignano was confirmed this week to lead the Social Security Administration (SSA), a group of 15 House Republicans is now urging him to seriously address some of the lingering issues within the agency — including problems exacerbated by President Donald Trump's administration.

The Arizona Republic recently reported that a group of 15 House Republicans who are predominantly from swing districts co-signed a letter to Bisignano about their "concerns" with the SSA following his Tuesday confirmation vote. In the letter — which the Republic's Laura Gersony observed "alternated between praise and polite uneasiness" — the lawmakers told Bisignano that they hoped he would use his time as commissioner to focus on improving the SSA's increasingly poor customer service.

"We commend and support the continued efforts to make our bloated bureaucracy more efficient for the American people," the 15 Republicans wrote. "However, we must use caution and consider the impact any changes would have so there are no disruptions in services for our seniors and disabled who depend on the Social Security Administration to receive retirement benefits and supplemental security income."

The letter comes on the heels of a statement by former acting SSA commissioner Leland Dudek, who led the SSA after former acting commissioner Michelle Wolf resigned in February after she clashed with Department of Government Efficiency (DOGE) representatives. Dudek acknowledged the long wait times and packed lobbies that have long plagued retirees — but blamed them on former President Joe Biden's administration "advancing radical DEI [diversity, equity and inclusion] and gender ideology over improving service for all Americans."

Dudek also spearheaded an effort to downsize the SSA's 57,000-member workforce, and convinced roughly 3,000 of them to take buyouts. Last month, the SSA announced that all official communications would be done exclusively through X (which is owned by DOGE co-founder and Tesla CEO Elon Musk) rather than issue press releases. DOGE also cancelled leases for SSA offices in multiple rural communities, meaning that retirees and disabled people who depend on Social Security now have to drive for several hours to their nearest office just to have basic questions answered.

Advocates warned that those measures could result in eligible recipients losing benefits they are entitled to through no fault of their own, given that many beneficiaries are elderly and may not have the ability to use new technology or leave their home to travel to an SSA office.

""I wish I had a better answer for people, but this is going to end in checks not going out, the money that we have earned not getting into our hands," Social Security Works executive director Alex Lawson told MSNBC host Rachel Maddow in April. "And I believe strongly that that's the point. The cuts they've made have no other rhyme or reason except to literally destroy the system."

Reprinted with permission from Alternet.

Tariffs, Jobs And Why You Should Care About Poverty In Bangladesh

Tariffs, Jobs And Why You Should Care About Poverty In Bangladesh

I’ve returned from Europe to the United States. Miraculously, my flight to Newark landed on time. So this seems like a good day to write about … Bangladesh. I’ll explain shortly.

First, a note on the current state of the trade war. Many people, including many small investors, still believe and/or hope either that Donald Trump will soon negotiate many trade deals or that he will claim he has, declare victory, and back off his massive tariff hike. They’re deluding themselves.

Consider what we’ve learned about Trump as the negative fallout from his tariffs has started to become obvious.

First, he’s invincibly ignorant. The collapse of imports from China has businesses terrified and warning both of soaring consumer prices and of looming shortages. But Trump says it’s all good:

We were losing hundreds of billions of dollars with China. Now we’re essentially not doing business with China. Therefore, we’re saving hundreds of billions of dollars. Very simple.

Hey, remember those empty shelves during Covid? Americans were doing great! Think of all the money they saved by not buying toilet paper, because there was none to be had. Very simple.

Second, when he’s in a hole, he just keeps digging. His talk about making Canada the 51st state had a decisive effect in Canada’s recent election, hugely bolstering anti-Trump forces. But yesterday, meeting with Prime Minster Mark Carney, who kept his office thanks to this backlash, Trump kept pushing the idea.

Carney remained polite — he is, after all, Canadian — but his facial expressions during the meeting were something to behold.

The best bet, then, is that the trade war will proceed, even intensify. There will be some winners, at least in terms of global influence, including China, which gains from America’s loss of credibility, and the European Union, which unlike Trump’s America can be trusted to honor its agreements. The United States will be a big loser, both politically and economically.

But the biggest losers will be poor countries that have become less poor largely thanks to exports and are about to see their hopes of progress dashed.

Possibly the most hated article I’ve ever written was a 1997 piece for Slate titled “In Praise of Cheap Labor,” which was mainly aimed at left-wing critics of globalization. I argued that much as the sight of low-paid workers producing cheap goods for rich countries may — and should — disturb us, labor-intensive exports are often poor countries’ best hope of progress.

This argument has only become stronger over time. The New York Times recently had a very good article on Bangladesh, which 50 years ago was the poster child for warnings about mass famine driven by overpopulation. Instead, the South Asian nation became, not a banana republic, but a pajama republic, one of the world’s leading clothing exporters. It’s still a poor country, with wages and working conditions that are appalling by advanced-country standards. But as the chart at the top of this post shows, Bangladesh is about four times as rich as it was in the 1980s, when its exports began rising.

But now the country faces the possibility of economic catastrophe, made in America. Trump’s “Liberation Day” trade plan would have imposed a 37 percent tariff on imports from Bangladesh. That plan is temporarily on hold, but it seems all too possible that it or something as bad or worse will come back.

OK, I know that most Americans don’t care about Bangladeshi living standards. They should, even on selfish grounds: condemning 170 million people to deeper poverty would be a threat to global stability. But here’s the thing: Throwing up barriers to Bangladeshi exports doesn’t involve a tradeoff, helping American workers at others’ expense. It’s pure loss, hurting both nations.

Why? Because making imported clothing more expensive here won’t create U.S. jobs. Apparel production, still largely carried out by people hunched over sewing machines, is just too labor-intensive to be economically feasible in the United States, no matter how high the tariffs.

Trump’s people don’t seem to get that. True, Howard Lutnick, the Commerce Secretary, famously claimed that tariffs could indeed create jobs in labor-intensive activities, although he didn’t use clothing as an example:

The armies of millions of people- well, remember, the army of millions and millions of human beings screwing in little- little screws to make iPhones, that kind of thing is going to come to America.

Um, no it isn’t, and shouldn’t.

Taxes on imported clothing will, however, raise Americans’ cost of living. The poor and the working class, who are more likely to buy inexpensive imported clothing, will be hurt worst. But hey, Trump says that children don’t need multiple dolls; why do their parents need multiple pairs of underwear?

Not incidentally, Greg Sargent looked into what it would actually take to manufacture dolls in the United States. Even if it could be done, it would produce only a handful of jobs — and the jobs would be terrible and pay badly.

The point is that Trump and his team have done something remarkable: They have started a trade war that is bad both for Americans and for countries that sell to us. But Trump is unlikely to change course. The economic punishment will continue until morale improves.

Paul Krugman is a Nobel Prize-winning economist and former professor at MIT and Princeton who now teaches at the City University of New York's Graduate Center. From 2000 to 2024, he wrote a column for The New York Times. Please consider subscribing to his Substack, where he now posts almost every day.

Reprinted with permission from Paul Krugman.

Shop our Store

Headlines

Editor's Blog

Corona Virus

Trending

World